Recent years have seen an explosion of innovation in health care and life sciences. In 2023, the FDA approved the world’s first CRISPR therapy to treat sickle cell disease and a new treatment for Alzheimer’s disease. The advent of generative AI, digital devices and wearables has also opened new frontiers, driving advancements that redefine how we approach, develop and experience medical care.
Panel: Consumer Health Technology
Corinne Bain, Senior Product Manager, Lark Health
Michael Chapp, COO, Oura
Dr. Jeff Chen, CEO, Radicle Science
Dr. James Mault, Founder and CEO, BioIntellisense; SVP, Qualcomm
Read more about the UCLA Anderson Healthcare Business Association’s annual Vitals conference:
www.anderson.u...
#healthtech #diagnostics #personalizedmedicine